Targeting Α7Nachr Mitigates Vascular Aging And Endothelial Cell Senescence Through Inhibiting Oxidative Stress And Inflammation Via Α7Nachr/Nrf2/HO-1 Signaling Pathway
Vascular aging, the stiffening and dysfunction of our blood vessels over time, is a major contributor to many age-related diseases. This process is often driven by two key culprits: oxidative stress, which is an imbalance between harmful free radicals and the body’s ability to counteract them, and inflammation, the body’s immune response that can become chronic and damaging.
Recent research has shed light on a promising target to combat these issues: a protein called alpha7 nicotinic acetylcholine receptor (α7nAChR). This receptor plays a crucial role in regulating various cellular processes, including inflammation.
Studies show that by activating or “targeting” α7nAChR, it’s possible to reduce both oxidative stress and inflammation within the endothelial cells, which are the cells lining our blood vessels. This, in turn, helps to mitigate the aging of these vessels. The mechanism behind this beneficial effect appears to involve a specific cellular communication pathway. This pathway involves α7nAChR interacting with Nrf2, a master regulator of antioxidant responses in the body, and subsequently activating HO-1, an enzyme with strong anti-inflammatory and antioxidant properties. By bolstering this pathway, the body can better protect its blood vessels from the detrimental effects of aging. This discovery suggests that α7nAChR could be a valuable therapeutic target for developing new strategies to prevent or treat vascular aging and related diseases.
Source: link to paper